Anti-dementia drugs, such as cholinesterase inhibitors (ChEIs) (e.g., donepezil, rivastigmine, and galantamine), have shown improvement in mild to moderate dementia and have effects on negative symptoms (e.g., apathy, irritability, and depression). Here, BCHE is linked to dementia.